User menu

Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor {alpha} Homodimers.

Bibliographic reference Hornakova, Tekla ; Staerk, Judith ; Royer, Yohan ; Flex, Elisabetta ; Tartaglia, Marco ; et. al. Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor {alpha} Homodimers.. In: The Journal of biological chemistry, Vol. 284, no. 11, p. 6773-81 (2009)
Permanent URL http://hdl.handle.net/2078.1/22119
  1. Constantinescu S. N., Keren T., Socolovsky M., Nam H.-s., Henis Y. I., Lodish H. F., Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain, 10.1073/pnas.081069198
  2. Schindler Christian, Levy David E., Decker Thomas, JAK-STAT Signaling: From Interferons to Cytokines, 10.1074/jbc.r700016200
  3. Staerk Judith, Kallin Anders, Demoulin Jean-Baptiste, Vainchenker William, Constantinescu Stefan N., JAK1 and Tyk2 Activation by the Homologous Polycythemia Vera JAK2 V617F Mutation : CROSS-TALK WITH IGF1 RECEPTOR, 10.1074/jbc.c500358200
  4. Walters Denise K., Mercher Thomas, Gu Ting-Lei, O'Hare Thomas, Tyner Jeffrey W., Loriaux Marc, Goss Valerie L., Lee Kimberly A., Eide Christopher A., Wong Matthew J., Stoffregen Eric P., McGreevey Laura, Nardone Julie, Moore Sandra A., Crispino John, Boggon Titus J., Heinrich Michael C., Deininger Michael W., Polakiewicz Roberto D., Gilliland D. Gary, Druker Brian J., Activating alleles of JAK3 in acute megakaryoblastic leukemia, 10.1016/j.ccr.2006.06.002
  5. Flex Elisabetta, Petrangeli Valentina, Stella Lorenzo, Chiaretti Sabina, Hornakova Tekla, Knoops Laurent, Ariola Cristina, Fodale Valentina, Clappier Emmanuelle, Paoloni Francesca, Martinelli Simone, Fragale Alessandra, Sanchez Massimo, Tavolaro Simona, Messina Monica, Cazzaniga Giovanni, Camera Andrea, Pizzolo Giovanni, Tornesello Assunta, Vignetti Marco, Battistini Angela, Cavé Hélène, Gelb Bruce D., Renauld Jean-Christophe, Biondi Andrea, Constantinescu Stefan N., Foà Robin, Tartaglia Marco, Somatically acquiredJAK1mutations in adult acute lymphoblastic leukemia, 10.1084/jem.20072182
  6. Jeong E. G., Kim M. S., Nam H. K., Min C. K., Lee S., Chung Y. J., Yoo N. J., Lee S. H., Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers, 10.1158/1078-0432.ccr-07-4839
  7. Oncogene, 9, 1327 (1994)
  8. Blood, 78, 1311 (1991)
  9. Fischer M, Bijman M, Molin D, Cormont F, Uyttenhove C, van Snick J, Sundström C, Enblad G, Nilsson G, Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma, 10.1038/sj.leu.2403123
  10. Blood, 77, 1436 (1991)
  11. Uyttenhove C., Autonomous growth and tumorigenicity induced by P40/interleukin 9 cDNA transfection of a mouse P40-dependent T cell line, 10.1084/jem.173.2.519
  12. Cancer Res., 60, 3971 (2000)
  13. James Chloé, Ugo Valérie, Le Couédic Jean-Pierre, Staerk Judith, Delhommeau François, Lacout Catherine, Garçon Loïc, Raslova Hana, Berger Roland, Bennaceur-Griscelli Annelise, Villeval Jean Luc, Constantinescu Stefan N., Casadevall Nicole, Vainchenker William, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera, 10.1038/nature03546
  14. Knoops Laurent, Renauld Jean-Christophe, IL-9 and its Receptor: From Signal Transduction to Tumorigenesis, 10.1080/08977190410001720879
  15. Demoulin J B, Uyttenhove C, Van Roost E, DeLestré B, Donckers D, Van Snick J, Renauld J C, A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9., 10.1128/mcb.16.9.4710
  16. J. Immunol., 145, 2494 (1990)
  17. Haan Claude, Is'harc Hayaatun, Hermanns Heike M., Schmitz-Van de Leur Hildegard, Kerr Ian M., Heinrich Peter C., Grötzinger Joachim, Behrmann Iris, Mapping of a Region within the N Terminus of Jak1 Involved in Cytokine Receptor Interaction, 10.1074/jbc.m106135200
  18. Liu Xuedong, Constantinescu Stefan N., Sun Yin, Bogan Jonathan S., Hirsch David, Weinberg Robert A., Lodish Harvey F., Generation of Mammalian Cells Stably Expressing Multiple Genes at Predetermined Levels, 10.1006/abio.2000.4478
  19. Renauld J. C., Druez C., Kermouni A., Houssiau F., Uyttenhove C., Van Roost E., Van Snick J., Expression cloning of the murine and human interleukin 9 receptor cDNAs., 10.1073/pnas.89.12.5690
  20. Gerland Katia, Bataillé-Simoneau Nelly, Baslé Michel, Fourcin Maryvonne, Gascan Hugues, Mercier Louis, Activation of the Jak/Stat signal transduction pathway in GH-treated rat osteoblast-like cells in culture, 10.1016/s0303-7207(00)00314-2
  21. Peelman Frank, Iserentant Hannes, De Smet Anne-Sophie, Vandekerckhove Joël, Zabeau Lennart, Tavernier Jan, Mapping of Binding Site III in the Leptin Receptor and Modeling of a Hexameric Leptin·Leptin Receptor Complex, 10.1074/jbc.m512622200
  22. Dumoutier L., Van Roost E., Colau D., Renauld J.-C., Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor, 10.1073/pnas.170291697
  23. Saharinen P., Takaluoma K., Silvennoinen O., Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain, 10.1128/mcb.20.10.3387-3395.2000
  24. Kralovics Robert, Passamonti Francesco, Buser Andreas S., Teo Soon-Siong, Tiedt Ralph, Passweg Jakob R., Tichelli Andre, Cazzola Mario, Skoda Radek C., A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders, 10.1056/nejmoa051113
  25. Baba Hirofumi, Yamada Yasuaki, Mori Naoki, Hayashibara Toshihisa, Harasawa Hitomi, Tsuruda Kazuto, Sugahara Kazuyuki, Soda Hiroshi, Takasaki Yumi, Tawara Masayuki, Hirakata Yoichi, Tomonaga Masao, Kamihira Shimeru, Multiple gammac-receptor expression in adult T-cell leukemia, 10.1034/j.1600-0609.2002.00653.x
  26. Blood, 85, 1300 (1995)
  27. Vink Anne, Renauld Jean-Christophe, Warnier Guy, Van Snick Jacques, Interleukin-9 stimulatesin vitro growth of mouse thymic lymphomas, 10.1002/eji.1830230523
  28. Brown Richard J, Adams Julian J, Pelekanos Rebecca A, Wan Yu, McKinstry William J, Palethorpe Kathryn, Seeber Ruth M, Monks Thea A, Eidne Karin A, Parker Michael W, Waters Michael J, Model for growth hormone receptor activation based on subunit rotation within a receptor dimer, 10.1038/nsmb977
  29. Malka Yaniv, Hornakova Tekla, Royer Yohan, Knoops Laurent, Renauld Jean-Christophe, Constantinescu Stefan N., Henis Yoav I., Ligand-independent Homomeric and Heteromeric Complexes between Interleukin-2 or -9 Receptor Subunits and the γ Chain, 10.1074/jbc.m803125200
  30. Hideshima T., Advances in biology of multiple myeloma: clinical applications, 10.1182/blood-2004-01-0037
  31. Bromberg Jacqueline, Darnell James E, The role of STATs in transcriptional control and their impact on cellular function, 10.1038/sj.onc.1203476
  32. Kawamura M., McVicar D. W., Johnston J. A., Blake T. B., Chen Y. Q., Lal B. K., Lloyd A. R., Kelvin D. J., Staples J. E., Ortaldo J. R., Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes., 10.1073/pnas.91.14.6374
  33. Johnston James A., Kawamura Masaru, Kirken Robert A., Chen Yi-Qing, Blake Trevor B., Shibuya Kyoichi, Ortaldo John R., McVicar Daniel W., O'Shea John J., Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2, 10.1038/370151a0
  34. Nakarai T., Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells, 10.1084/jem.180.1.241
  35. Levine Ross L., Wadleigh Martha, Cools Jan, Ebert Benjamin L., Wernig Gerlinde, Huntly Brian J.P., Boggon Titus J., Wlodarska Iwona, Clark Jennifer J., Moore Sandra, Adelsperger Jennifer, Koo Sumin, Lee Jeffrey C., Gabriel Stacey, Mercher Thomas, D’Andrea Alan, Fröhling Stefan, Döhner Konstanze, Marynen Peter, Vandenberghe Peter, Mesa Ruben A., Tefferi Ayalew, Griffin James D., Eck Michael J., Sellers William R., Meyerson Matthew, Golub Todd R., Lee Stephanie J., Gilliland D. Gary, Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis, 10.1016/j.ccr.2005.03.023
  36. Noguchi M, Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans, 10.1016/0092-8674(93)90167-o
  37. BAXTER E, SCOTT L, CAMPBELL P, EAST C, FOUROUCLAS N, SWANTON S, VASSILIOU G, BENCH A, BOYD E, CURTIN N, Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders, 10.1016/s0140-6736(05)74230-6
  38. Hematology Am. Soc. Hematol. Educ. Program, 2005, 195 (2005)
  39. Wernig G., Gonneville J. R., Crowley B. J., Rodrigues M. S., Reddy M. M., Hudon H. E., Walz C., Reiter A., Podar K., Royer Y., Constantinescu S. N., Tomasson M. H., Griffin J. D., Gilliland D. G., Sattler M., The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes, 10.1182/blood-2007-07-102186
  40. Lu X., Levine R., Tong W., Wernig G., Pikman Y., Zarnegar S., Gilliland D. G., Lodish H., Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation, 10.1073/pnas.0509714102
  41. Lu Xiaohui, Huang Lily Jun-Shen, Lodish Harvey F., Dimerization by a Cytokine Receptor Is Necessary for Constitutive Activation of JAK2V617F, 10.1074/jbc.m707125200